Kangmei Internet + play crazy: Hand in hand Xinhuanet to take a healthy big data platform
Recently, Kangmei Pharmaceutical announced that the company will jointly invest 300 million yuan with Xinhuanet to establish Kangmei Health Think Tank Co., Ltd., with shares accounting for 57% and 43% respectively. Considering the company's previous layout in Internet medical care , analysts believe that the cooperation between the two will build the underlying data support for the nationwide Internet medical platform for Kangmei Pharmaceutical.
According to the announcement, the two parties will use their respective advantageous resources to build the most authoritative health big data platform in China with Kangmei Health Think Tank as the carrier, carry out health data mining, search, precision marketing, product development, chronic disease. Application products and business lines such as management, health consultation, education and training, and provide data support for government decision-making and business operations, and provide health information services for middle and high-end people.
In the past week or two, Kangmei Pharmaceutical has issued an announcement frequently, from the proposed establishment of Kangmei Health Cloud Service Co., Ltd. to sign the "Internet Medical Health Service Cooperation Agreement" with the Puning Municipal Government, and then acquires 74% of the shares of McKinley Industrial to RMB 82.73 million. . Basically all cooperation has the brand of the Internet.
Good wind relies on strength, send me to Qingyun, now God is the stock price of Kangmei Pharmaceutical. As of May 27, Hengrui Pharmaceutical (share price rose 5.19%, total market value reached 101.2 billion yuan, becoming the first pharmaceutical listed company to enter the 100 billion yuan market value club. Kangmei Pharmaceutical followed closely, June 4th The market value is 99.2 billion yuan, and it seems that entering the "100 billion clubs" is just around the corner.
According to Guoxin Securities' analysis, Kangmei Pharmaceutical is currently forming a nationwide “super-platform†of Internet medical care, on which the complete ecosystem of virtual hospitals is realized. In the process of rapid advancement of the national strategy of Internet medical care, the underlying data support is the basis of all strategies.
At present, Kangmei Pharmaceutical has a wide range of medical resources nationwide, including self-built or hosted hospitals in Puning, Guangzhou, Northeast China, Qinghai, Guangxi, etc., which will provide physical support for the company to develop network hospital business. And a bigger one is also trapping consumers to buy medicine. For example, Kangmei Pharmaceutical has already piloted “virtual pharmacies†with professional e-commerce companies in Guangzhou, Shenzhen, Beijing and Chengdu. At present, several provincial-level Chinese medicine hospitals have connected to the Kangmei network platform. On the one hand, the company directly reads these hospitals. The electronic prescription is concentrated and dispensed to the patient's home, thus forming the basis for online prescription drugs.
Samsung Electric will increase 5 billion plus yards of smart medical care
Kangmei Pharmaceutical is a listed company in the traditional pharmaceutical industry. Seeing the good situation of the pharmaceutical sector, there are also listed companies in the non-traditional medical industry .
Less than a month after the suspension of trading, Samsung Electric quickly launched a heavyweight increase plan. The company plans to raise about 5.018 billion yuan to raise the main business. On the one hand, it actively expands the scale of operation of Fuzhou Hospital and the construction of 300 grassroots medical institutions in Ningbo. It will form a regional health medical service platform integrating health management, remote monitoring, remote diagnosis and treatment, community rehabilitation and wearable devices to create a complete intelligent medical service industry chain.
The plan shows that the company intends to issue no more than 130 million shares to no more than 10 specific targets at a reserve price of 38.64 yuan per share, raising a total of 5.018 billion yuan. Among them, 2.5 billion yuan was used for the construction of 300 grassroots medical institutions in Ningbo, about 1.71 billion yuan was invested in the reconstruction and expansion of Fuzhou Hospital, and the remaining 810 million yuan was invested in the expansion and intelligent upgrading of intelligent environmental protection power distribution equipment.
The reconstruction and expansion project of Fuzhou Hospital includes two parts of the expansion project of Mingzhou Hospital and the construction of Fuzhou Hospital (Fuzhou Mingzhou Hospital) affiliated to Nanchang University. Among them, the investment project of Mingzhou Hospital is 710 million yuan, and that of Fuzhou Mingzhou Hospital is 1 billion yuan. The company said that after the expansion of Mingzhou Hospital, it will help improve the medical environment and medical level of the hospital and alleviate the local medical resources in Ningbo. The Fuzhou Mingzhou Hospital Project can make full use of the teaching, medical and scientific research resources of the Fuzhou Medical College of Nanchang University. Advantages to improve the level of local medical services.
In Ningbo, the project will build 300 grassroots chain medical institutions in Ningbo, and simultaneously build cloud medical and management platforms and remote medical treatment points.
Since the resumption of trading on June 2, Samsung Electric has been trading at a “one-word†daily limit. I have to say that the power of the concept is really big.
COVID-19 Saliva Midstream,Self-check COVID-19 Test,Saliva Midstream Test,COVID-19 Antigen Test Saliva Midstream
Weihai Kangzhou Biotechnology Engineering Co.,Ltd , https://www.weihaikangzhou.com